Stage and resectability
Treatment planning often begins by determining whether the tumor is resectable, borderline resectable, locally advanced or metastatic.
Pancreatic cancer treatment is planned according to tumor stage, location, resectability, vessel involvement, metastatic spread, performance status, biomarker profile, symptoms and personal care goals. Treatment may include surgery, chemotherapy, radiation therapy, chemoradiation, targeted therapy, clinical trials, symptom relief and supportive care.
A multidisciplinary team may include medical oncology, surgical oncology, radiation oncology, gastroenterology, radiology, pathology, nutrition, pain management, palliative care and supportive-care specialists.
Treatment planning often begins by determining whether the tumor is resectable, borderline resectable, locally advanced or metastatic.
Germline and tumor testing may identify BRCA1/2, PALB2, mismatch repair, MSI-H, NTRK or other features that can influence treatment discussion.
Pain, jaundice, digestion, appetite, weight loss, diabetes, fatigue and bile duct obstruction may need care alongside cancer-directed treatment.
This schema organizes treatment concepts from diagnosis and staging to surgery, systemic therapy, radiation, biomarker-guided care, clinical trials and support.
Treatment approaches may be used alone, in sequence or in combination depending on stage, tumor biology, resectability and patient health.
Surgery may be considered when the tumor can be removed safely and there is no distant metastatic spread.
Local treatmentAlso called pancreaticoduodenectomy, this surgery is commonly used for tumors in the head of the pancreas.
Pancreatic head tumorsSurgery that removes the body or tail of the pancreas and sometimes the spleen, depending on tumor location.
Body or tail tumorsChemotherapy is used before surgery, after surgery, for locally advanced cancer, metastatic cancer or recurrence, depending on the plan.
Systemic treatmentChemotherapy, sometimes with radiation, may be given before surgery in borderline resectable or selected resectable cases.
Before surgeryTreatment after surgery may help reduce the risk of recurrence and can include chemotherapy or chemoradiation in selected cases.
After surgeryRadiation may be used with chemotherapy in selected localized or locally advanced cases, or to help relieve symptoms.
Local controlBiomarker-guided options may be discussed for selected tumors with actionable features such as BRCA-related DNA repair changes, MSI-H/dMMR or NTRK fusions.
Biomarker guidedPancreatic cancer treatment is often described by surgical possibility: resectable, borderline resectable, locally advanced or metastatic.
Surgery may be possible. Treatment may include surgery plus chemotherapy before and/or after surgery depending on individual factors.
Treatment often begins with chemotherapy, sometimes followed by radiation, then reassessment for possible surgery.
Cancer involves nearby structures or major vessels. Treatment may include chemotherapy, chemoradiation, symptom procedures and clinical trials.
Treatment usually focuses on systemic therapy, biomarker-guided options, symptom control, clinical trials and supportive care.
Systemic therapy travels through the body and can treat cancer cells beyond the pancreas. It may be used before surgery, after surgery, for locally advanced disease, metastatic disease or recurrence.
A multi-drug chemotherapy approach used in selected patients depending on health status, treatment goals and tolerance.
Gemcitabine, sometimes combined with nab-paclitaxel or other medicines, is a commonly discussed chemotherapy approach.
BRCA1, BRCA2, PALB2 or related DNA repair findings may influence platinum or PARP-inhibitor discussions in selected cases.
Immunotherapy is not broadly effective for most pancreatic cancers, but may be relevant for rare biomarker-defined tumors such as MSI-H or dMMR cancers.
Supportive care helps manage symptoms, side effects and quality of life at any stage of pancreatic cancer. It can be provided alongside cancer-directed treatment.
Stenting or drainage procedures may be used when bile flow is blocked and symptoms need relief.
Pain support may include medicines, nerve blocks, radiation for symptom relief or palliative-care support.
Dietitian support and pancreatic enzyme replacement may help digestion, weight loss, appetite and stool changes.
Blood-sugar monitoring, energy planning and supportive care may help manage metabolic and treatment-related changes.
Side effects depend on treatment type, dose, schedule, surgery, radiation field, drug combination and personal health factors.
Ask about wound care, infection signs, digestion, enzyme needs, diabetes changes, pain and recovery time.
Track fatigue, nausea, diarrhea, appetite loss, neuropathy, infection risk, mouth sores and blood counts.
Ask about nausea, fatigue, skin effects, appetite changes, bowel irritation and treatment schedule.
Side effects vary by medicine and biomarker context, so monitoring plans should be reviewed clearly.
These questions can help patients and caregivers organize treatment discussions.
Pancreatic cancer trials may study chemotherapy combinations, targeted therapy, immunotherapy, vaccines, KRAS-directed approaches, stromal targeting, radiation strategies, supportive-care approaches and biomarker-guided treatment.
Pancreatic cancer treatment may involve cancer-directed therapy and supportive care, depending on whether the tumor can be removed and whether it has spread.
Common treatment approaches include surgery, chemotherapy, radiation therapy, chemoradiation, targeted therapy, clinical trials, palliative care and supportive care.
The Whipple procedure, also called pancreaticoduodenectomy, is surgery often used for tumors in the head of the pancreas.
Supportive care can help manage pain, jaundice, digestion, weight loss, enzyme needs, diabetes changes, fatigue and emotional stress.
Clear answers to common pancreatic cancer treatment questions.
Main treatment approaches may include surgery, chemotherapy, radiation therapy, chemoradiation, targeted therapy, clinical trials, palliative therapy and supportive care.
The Whipple procedure, or pancreaticoduodenectomy, is an operation often used for pancreatic tumors located in the head of the pancreas.
Chemotherapy options may include multi-drug regimens such as FOLFIRINOX-based therapy or gemcitabine-based therapy, depending on stage, health status and treatment goals.
Immunotherapy is not broadly used for most pancreatic cancers, but it may be relevant for selected tumors with biomarkers such as MSI-H or dMMR.
No. This page is educational only and does not replace consultation with a qualified healthcare professional.
Authoritative sources used to support this pancreatic cancer treatment education page.